Putnam New York Investment Grade Municipal Trust PMN 深滬

等待開盤 11-19 09:30:00 美东时间

0.3631

+0.002

+0.61%

華盛通

立即下載

最高0.3708
今開0.352
成交量 34.91万股
最低 0.35
昨收 0.3609
總市值 1186.94万
52周最高 1.59
市盈率 ^靜 3.46
換手率 1.07%
52周最低 0.35
委比 77.59%
總股本 3268.92万
歷史最高 9.80
量比 0.80
振幅 5.76%
歷史最低 0.35
每手 1
風險率 0.21%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

美股大行评级 | Stifel上调英伟达目标价升至250美元；大摩上调哔哩哔哩目标价升至27美元；NICE遭多家机构下调目标价

今日重点评级关注：Oppenheimer：维持Olema Pharmaceuticals"跑赢大市"评级，目标价从22美元升至45美元；Bernstein：维持Atlassian"跑赢大市"评级，目标价从290美元升至304美元

今天 11:01
Guggenheim Maintains Buy on ProMIS Neurosciences, Lowers Price Target to $5

Guggenheim analyst Eddie Hickman maintains ProMIS Neurosciences (NASDAQ:PMN) with a Buy and lowers the price target from $6 to $5.

11-18 22:49
ProMIS Neurosciences shares are trading higher. The company reported Q3 financial results.

ProMIS Neurosciences shares are trading higher. The company reported Q3 financi...

11-13 00:56
ProMIS Neurosciences Q3 EPS $(0.24), Inline

ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.24) per share which met the analyst consensus estimate. This is a 177.42 percent decrease over earnings of $0.31 per share from the same period last

11-12 20:15
ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group

ProMIS Neurosciences has announced the appointment of Slanix Paul Alex, Pharm.D., to its Board of Directors. Dr. Alex, a prominent Wall Street figure with extensive experience in healthcare investment and biotechnology research, will offer valuable insights into capital markets and biopharma trends. His加入 is expected to strengthen investor engagement as the company advances its Alzheimer’s candidate, PMN310, including planned data readouts from t...

10-22 11:30
ProMIS Neurosciences Amends Employment Agreement with CSO

The latest update is out from ProMIS Neurosciences ( ($PMN) ). On September 26,...

10-01 04:54
Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging Demographics

USA News Group News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Sept. 18, 2025 /PRNewswire/ -- USA News Group News Commentary –Today, Americans over 65 command $22,...

09-18 21:10
ProMIS Neurosciences Advances Alzheimer’s Trial to Final Phase

ProMIS Neurosciences ( ($PMN) ) has issued an update. On September 3, 2025, Pro...

09-03 19:29
PMN up: ProMIS Neurosciences shares are trading higher after the Data and Safety Monitoring Board recommended the company proceed to the third dose escalation cohort in its PRECISE-AD Phase 1b Alzheimer's trial.

PMN up: ProMIS Neurosciences shares are trading higher after the Data and Safet...

09-03 19:08
ProMIS Neurosciences Receives DSMB Approval to Advance to Final Dose Escalation Cohort in Phase 1b Alzheimer’s Trial of PMN310

ProMIS Neurosciences announced the Data and Safety Monitoring Board (DSMB) has recommended advancing Cohort 3 of its PRECISE-AD Phase 1b trial for PMN310, a therapy targeting Alzheimer's disease. Cohort 2 has been fully enrolled with no amyloid-related imaging abnormalities (ARIA) observed. Cohort 3 enrollment is underway, aiming for 128 patients. Interim 6-month data is expected in Q2 2026, and final 12-month results in Q4 2026. PMN310 is design...

09-03 11:00

派息除權日	每股總股息	派息日期
2007-05-22	0.04	2007-06-01
2007-04-20	0.04	2007-05-01
2007-03-21	0.04	2007-04-02
2007-02-16	0.04	2007-03-01
2007-01-22	0.04	2007-02-01
2006-12-20	0.05	2007-01-02
2006-11-21	0.04	2006-12-01
2006-10-20	0.04	2006-11-01
2006-09-20	0.04	2006-10-02
2006-08-21	0.04	2006-09-01
2006-07-20	0.04	2006-08-01
2006-06-21	0.04	2006-07-03
2006-05-22	0.04	2006-06-01
2006-04-20	0.04	2006-05-01
2006-03-22	0.04	2006-04-03
2006-02-16	0.04	2006-03-01
2006-01-20	0.04	2006-02-01
2005-12-20	0.04	2006-01-03
2005-11-21	0.04	2005-12-01
2005-10-20	0.04	2005-11-01
2005-09-21	0.04	2005-10-03
2005-08-22	0.04	2005-09-01
2005-07-20	0.04	2005-08-01
2005-06-22	0.04	2005-07-01
2005-05-20	0.05	2005-06-01
2005-04-20	0.05	2005-05-02
2005-03-22	0.05	2005-04-01
2005-02-18	0.05	2005-03-01
2005-01-20	0.05	2005-02-01
2004-12-21	0.06	2005-01-03
2004-11-22	0.06	2004-12-01
2004-10-20	0.06	2004-11-01
2004-09-22	0.06	2004-10-01
2004-08-20	0.06	2004-09-01
2004-07-21	0.06	2004-08-02
2004-06-22	0.06	2004-07-01
2004-05-20	0.06	2004-06-01
2004-04-21	0.06	2004-05-03
2004-03-22	0.06	2004-04-01
2004-02-20	0.06	2004-03-01
2004-01-21	0.06	2004-02-02
2003-12-22	0.06	2004-01-02
2003-11-20	0.06	2003-12-01
2003-10-22	0.06	2003-11-03
2003-09-22	0.06	2003-10-01
2003-08-20	0.06	2003-09-02
2003-07-22	0.06	2003-08-01
2003-06-20	0.06	2003-07-01
2003-05-21	0.06	2003-06-02
2003-04-22	0.06	2003-05-01
2003-03-20	0.06	2003-04-01
2003-02-20	0.06	2003-03-03
2003-01-16	0.06	2003-02-03
2002-12-18	0.07	2003-01-02
2002-11-18	0.06	2002-12-02
2002-10-17	0.06	2002-11-01
2002-09-18	0.06	2002-10-01
2002-08-16	0.06	2002-09-03
2002-07-18	0.06	2002-08-01
2002-06-18	0.06	2002-07-01
2002-05-16	0.06	2002-06-03
2002-04-18	0.06	2002-05-01
2002-03-18	0.06	2002-04-01
2002-01-17	0.06	2002-02-01
2001-12-18	0.06	2002-01-02
2001-11-16	0.06	2001-12-03
2001-10-18	0.06	2001-11-01
2001-09-18	0.06	2001-10-01
2001-08-16	0.06	2001-09-04
2001-07-18	0.06	2001-08-01
2001-06-18	0.06	2001-07-02
2001-05-17	0.06	2001-06-01
2001-04-18	0.06	2001-05-01
2001-03-16	0.06	2001-04-02
2001-02-15	0.06	2001-03-01
2001-01-18	0.06	2001-02-01
2000-12-18	0.07	2001-01-02
2000-11-16	0.07	2000-12-01
2000-10-18	0.07	2000-11-01
2000-09-18	0.07	2000-10-02
2000-08-17	0.07	2000-09-01
2000-07-18	0.07	2000-08-01
2000-06-16	0.07	2000-07-03
2000-05-18	0.07	2000-06-01
2000-04-18	0.07	2000-05-01
2000-03-16	0.07	2000-04-03
2000-02-17	0.07	2000-03-01
2000-01-18	0.07	2000-02-01
1999-12-16	0.07	2000-01-03
1999-11-18	0.07	1999-12-01
1999-10-18	0.07	1999-11-01
1999-09-16	0.07	1999-10-01
1999-08-18	0.07	1999-09-01
1999-07-16	0.07	1999-08-02
1999-06-17	0.07	1999-07-01
1999-05-18	0.07	1999-06-01
1999-04-16	0.07	1999-05-03
1999-03-18	0.07	1999-04-01
1999-02-18	0.07	1999-03-01
1999-01-15	0.07	1999-02-01
1998-12-17	0.07	1999-01-04
1998-11-18	0.07	1998-12-01
1998-10-16	0.07	1998-11-02
1998-09-17	0.07	1998-10-01
1998-08-18	0.07	1998-09-01
1998-07-16	0.07	1998-08-03
1998-06-18	0.07	1998-07-01
1998-05-18	0.07	1998-06-01
1998-04-16	0.07	1998-05-01
1998-03-18	0.07	1998-04-01
1998-02-18	0.07	1998-03-02
1998-01-15	0.07	1998-02-02
1997-12-18	0.07	1998-01-02
1997-11-18	0.07	1997-12-01
1997-10-16	0.07	1997-11-03
1997-09-18	0.07	1997-10-01
1997-08-18	0.07	1997-09-02
1997-07-17	0.07	1997-08-01
1997-06-18	0.07	1997-07-01
1997-05-16	0.07	1997-06-02
1997-04-17	0.07	1997-05-01
1997-03-18	0.07	1997-04-01
1997-02-18	0.07	1997-03-03
1997-01-15	0.07	1997-02-03
1996-12-18	0.07	1997-01-02
1996-11-18	0.07	1996-12-02
1996-10-17	0.07	1996-11-01
1996-09-18	0.07	1996-10-01
1996-08-16	0.07	1996-09-03
1996-07-18	0.07	1996-08-01
1996-06-18	0.07	1996-07-01
1996-05-16	0.07	1996-06-03
1996-04-18	0.07	1996-05-01
1996-03-18	0.07	1996-04-01
1996-02-15	0.07	1996-03-01
1996-01-18	0.07	1996-02-01
1995-12-18	0.07	1996-01-02
1995-11-16	0.08	1995-12-01
1995-10-18	0.08	1995-11-01
1995-09-18	0.08	1995-10-02
1995-08-17	0.08	1995-09-01
1995-07-19	0.08	1995-08-01
1995-06-16	0.08	1995-07-03
1995-05-16	0.08	1995-06-01
1995-04-13	0.08	1995-05-01
1995-03-14	0.08	1995-04-03
1995-02-14	0.08	1995-03-01
1995-01-13	0.08	1995-02-01
1994-12-14	0.17	1995-01-03
1994-11-15	0.08	1994-12-01
1994-10-14	0.08	1994-11-01
1994-09-14	0.08	1994-10-03
1994-08-16	0.08	1994-09-01
1994-07-14	0.08	1994-08-01
1994-06-14	0.08	1994-07-01
1994-05-16	0.08	1994-06-01
1994-04-14	0.08	1994-05-02
1994-03-15	0.08	1994-04-04
1994-02-15	0.08	1994-03-01
1994-01-13	0.08	1994-02-01
1993-12-14	0.23	1994-01-03
1993-11-16	0.08	1993-12-01
1993-10-14	0.08	1993-11-01
1993-09-14	0.08	1993-10-01
1993-08-16	0.08	1993-09-01
1993-07-14	0.08	1993-08-02
1993-06-15	0.08	1993-07-01
1993-05-14	0.08	1993-06-01
1993-04-14	0.08	1993-05-03
1993-03-16	0.08	1993-04-01
1993-02-16	0.08	1993-03-01
1993-01-13	0.08	1993-02-01

公司名稱	ProMIS Neurosciences, Inc.
行業分類	Biotechnology
業務描述	ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease. The company was founded by Neil Cashman and Vigen Nazarian on January 23, 2004 and is headquartered in Toronto, Canada.

Putnam New York Investment Grade Municipal Trust PMN 深 滬

0.3631

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

Putnam New York Investment Grade Municipal Trust PMN 深滬